Reports Q2 revenue $795.2M, consensus $778.48M. “It was a strong start to 2026 for Ryan Specialty (RYAN) in the face of continued and increasing industry headwinds,” said Patrick Ryan, Founder and Executive Chairman of Ryan Specialty. “We grew total revenue 15%, driven by organic growth of 11.8% and contributions from M&A. We grew Adjusted EBITDAC by 15.7% and Adjusted Diluted EPS by 20.5%. Our performance this quarter speaks to the dedication of our team, their ability to succeed in challenging times, and the diversified enterprise we have purposefully built over the years. Through one of the most efficient and effective insurance distribution platforms in the word, we are delivering innovative solutions for our clients – brokers, agents, and carriers, that are difficult to replicate elsewhere. While we expect the environment to remain considerably challenging in the near term, we are confident that our continued investment in the platform, paired with our ability to innovate alongside our clients and capital trading partners, will further strengthen our position as a leader in specialty insurance.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $68 from $70 at BofA
- Ryan Specialty price target lowered to $42 from $44 at Mizuho
- Ryan Specialty price target lowered to $43 from $49 at JPMorgan
- Ryan Specialty price target lowered to $40 from $45 at Cantor Fitzgerald
- Ryan Specialty price target lowered to $59 from $65 at UBS
